Roche focuses on diagnostics to help cut healthcare costs
It can enable patients to avoid unnecessary treatment in hospitals and reduce duration of their stay there
Singapore
GIVEN the sweeping trend in Asia - the growing middle class, a rapidly ageing population and an explosion of lifestyle diseases - Roche Diagnostics has pumped money into expanding its diagnostics value chain to help change medical practice and improve quality of care.
Managing director of Roche Diagnostics Asia-Pacific Lance Little told The Business Times that while diagnostics influences over 60 per cent of decisions made by doctors on treatments of diseases and disorders, and that it is essential when it comes to formulating medical guidelines, it receives only 2 per cent of healthcare funding worldwide.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
HCA beats first-quarter profit estimates on higher patient admissions
US FDA approves Pfizer’s gene therapy for rare bleeding disorder
EU toughens rules on Chinese fashion retailer Shein
Best World under fire from shareholders at AGM over dividends, director salaries
‘Extreme’ climate blamed for world’s worst wine harvest in 62 years
Sheng Siong Q1 net profit up 9.3% on higher revenue